PT  - JOURNAL ARTICLE
AU  - Inês Moreira
AU  - Ana Sofia Vilariça
AU  - Paula Alves
TI  - First report of a very rare complication in a case of nonsmall cell lung carcinoma
AID  - 10.1183/20734735.0107-2021
DP  - 2021 Dec 01
TA  - Breathe
PG  - 210107
VI  - 17
IP  - 4
4099  - http://breathe.ersjournals.com/content/17/4/210107.short
4100  - http://breathe.ersjournals.com/content/17/4/210107.full
SO  - Breathe2021 Dec 01; 17
AB  - While immune checkpoint inhibitors like pembrolizumab are promising agents for nonsmall cell lung carcinoma treatment, increased use is leading to increased immune-related adverse events, including endocrinopathies such as adrenal insufficiency. https://bit.ly/3iMfhUk